13 Results for "

PKA-I

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "PKA-I" in MCE Product Catalog:

  • Targets Recommended:
6
6 Publications Verification
Cat. No.: HY-100530D
CAS No.: 142439-94-9
Purity:  99.69%
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS sodium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS sodium salt is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-100530
CAS No.: 151837-09-1
Purity:  99.53%
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS triethylammonium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS triethylammonium salt is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
Cat. No.: HY-100530C
CAS No.: 142439-95-0
Purity:  99.45%
Sp-cAMPS sodium salt, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS sodium salt is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS sodium salt binds the PDE10 GAF domain with an EC50 of 40 μM .
loading...
    loading...
Cat. No.: HY-100530A
CAS No.: 73208-40-9
Target:  

PKA

Research Areas:  

Neurological Disease

Rp-cAMPS, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 µM and 4.5 µM, respectively) antagonist. Rp-cAMPS is resistant to hydrolysis by phosphodiesterases .
loading...
    loading...
Cat. No.: HY-120994B
CAS No.: 129693-13-6
Target:  

PKA

Sp-8-CPT-cAMPS, a cAMP analog, is a potent and selective activator of the cAMP-dependent protein kinas A (PKA I and PKA II). Sp-8-CPT-cAMPS selects site A of RI compares to site A of RII by 153-fold and site B of RII compares to site B of RI by 59-fold .
loading...
    loading...
Cat. No.: HY-100530B
CAS No.: 71774-13-5
Sp-cAMPS, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS binds the PDE10 GAF domain with an EC50 of 40 μM .
loading...
    loading...
Cat. No.: HY-110005
CAS No.: 93602-66-5
Sp-cAMPS triethylamine, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS triethylamine is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS triethylamine binds the PDE10 GAF domain with an EC50 of 40 μM .
loading...
    loading...
Cat. No.: HY-120994A
CAS No.: 129735-01-9
Target:  

PKA

Rp-8-CPT-cAMPS, a cAMP analog, is a potent and competitive antagonist of cAMP-induced activation of cAMP-dependent PKA I and II. Rp-8-CPT-cAMPS preferentially selects site A of RI compares to site A of RII and site B of RII compares to site B of RI .
loading...
    loading...
Cat. No.: HY-148827
CAS No.: 255810-66-3
Synonyms: HYBO-165
Target:  

PKA

Research Areas:  

Cancer

GEM231 is an 18mer antisense oligonucleotide targeting the mRNA of the PKA-I (RIα regulatory subunit of cAMP dependent protein kinase type I ). GEM231 induces cell growth arrest, apoptosis, and differentiation in a variety of cancer cell lines in vitro and in tumors in vivo.
loading...
    loading...
Cat. No.: HY-148827A
Synonyms: HYBO-165 sodium
Target:  

PKA

Research Areas:  

Cancer

GEM231 sodium is an 18mer antisense oligonucleotide targeting the mRNA of the PKA-I (RIα regulatory subunit of cAMP dependent protein kinase type I ). GEM231 sodium induces cell growth arrest, apoptosis, and differentiation in a variety of cancer cell lines in vitro and in tumors in vivo.
loading...
    loading...
Cat. No.: HY-134302
CAS No.: 59212-44-1
Synonyms: 8-Hexylamino-cAMP
Target:  

PKA

Research Areas:  

Others

8-HA-cAMP is a membrane-permeable cAMP analogue and an activator of cAMP-dependent protein kinase and PKA I. 8-HA-cAMP exerts metabolic stability towards mammalian cyclic nucleotide-responsive phosphodiesterases .
loading...
    loading...
Cat. No.: HY-120994
CAS No.: 221905-35-7
Target:  

PKA

Rp-8-CPT-cAMPS sodium, a cAMP analog, is a potent and competitive antagonist of cAMP-induced activation of cAMP-dependent PKA I and II. Rp-8-CPT-cAMPS sodium preferentially selects site A of RI compares to site A of RII and site B of RII compares to site B of RI .
loading...
    loading...
Cat. No.: HY-100530CR
CAS No.: 142439-95-0
Sp-cAMPS (sodium salt) (Standard) is the analytical standard of Sp-cAMPS (sodium salt) (HY-100530C). This product is intended for research and analytical applications. Sp-cAMPS sodium salt, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS sodium salt is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 µM. Sp-cAMPS sodium salt binds the PDE10 GAF domain with an EC50 of 40 μM .
loading...
    loading...
  • 1